Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

After 30 years … the future of hydroxyacids

After 30 years … the future of hydroxyacids Alpha‐hydroxyacids (AHAs) have transformed skin care and enjoyed huge commercial success since their introduction by dermatologist Dr Eugene J. Van Scott and dermatopharmacologist Dr Ruey J. Yu in the early 1970s. Thirty years have passed since the published introduction of AHAs, demonstrating their significant “normalizing” or corrective effects on severely dry skin and ichthyosis. It was not until the mid‐1990s, just 10 years ago, that the antiaging effects of AHAs became a prominent message in cosmetic dermatology, leading to a proliferation of AHA‐containing antiaging products and skin care systems. Today, AHAs and related compounds, including the polyhydroxy acids (PHAs) and polyhydroxy bionic acids (bionic acids), are used manifold in dermatology – cosmetically to achieve smoother skin, adjunctively with topical and systemic medications, and as a complement or enhancing agent with cosmetic procedures. Many companies have marketed AHA‐containing skin care products and, accordingly, consumer recognition of their beneficial effects is high. However, many of the important skin benefits of AHAs are not well understood by many consumers and other users of AHAs. Still viewed by many as simple exfoliants, the more significant effects of AHAs, including normalization of epidermal keratinization and dermal remodeling, are frequently overlooked. Moreover, the newer http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cosmetic Dermatology Wiley

After 30 years … the future of hydroxyacids

Journal of Cosmetic Dermatology , Volume 4 (1) – Jan 1, 2005

Loading next page...
 
/lp/wiley/after-30-years-the-future-of-hydroxyacids-rXiUFj8kV5
Publisher
Wiley
Copyright
Copyright © 2005 Wiley Subscription Services, Inc., A Wiley Company
ISSN
1473-2130
eISSN
1473-2165
DOI
10.1111/j.1473-2165.2005.00159.x
pmid
17134422
Publisher site
See Article on Publisher Site

Abstract

Alpha‐hydroxyacids (AHAs) have transformed skin care and enjoyed huge commercial success since their introduction by dermatologist Dr Eugene J. Van Scott and dermatopharmacologist Dr Ruey J. Yu in the early 1970s. Thirty years have passed since the published introduction of AHAs, demonstrating their significant “normalizing” or corrective effects on severely dry skin and ichthyosis. It was not until the mid‐1990s, just 10 years ago, that the antiaging effects of AHAs became a prominent message in cosmetic dermatology, leading to a proliferation of AHA‐containing antiaging products and skin care systems. Today, AHAs and related compounds, including the polyhydroxy acids (PHAs) and polyhydroxy bionic acids (bionic acids), are used manifold in dermatology – cosmetically to achieve smoother skin, adjunctively with topical and systemic medications, and as a complement or enhancing agent with cosmetic procedures. Many companies have marketed AHA‐containing skin care products and, accordingly, consumer recognition of their beneficial effects is high. However, many of the important skin benefits of AHAs are not well understood by many consumers and other users of AHAs. Still viewed by many as simple exfoliants, the more significant effects of AHAs, including normalization of epidermal keratinization and dermal remodeling, are frequently overlooked. Moreover, the newer

Journal

Journal of Cosmetic DermatologyWiley

Published: Jan 1, 2005

References